|
|
|
Volumn 43, Issue 7, 2002, Pages 7-13
|
|
Third-generation antidepressants: Do they offer advantages over the SSRIs?
a
a
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ALCOHOL;
AMITRIPTYLINE;
ANTIDEPRESSANT AGENT;
AVANZA;
CARBAMAZEPINE;
CIMETIDINE;
CLOMIPRAMINE;
COTHIEPIN;
DESIPRAMINE;
DIAZEPAM;
FLUOXETINE;
IMIPRAMINE;
MIRTAZAPINE;
NEFAZODONE;
PAROXETINE;
PLACEBO;
REBOXETINE;
SERTRALINE;
UNCLASSIFIED DRUG;
VENLAFAXINE;
AGRANULOCYTOSIS;
CARDIOVASCULAR DISEASE;
CLINICAL TRIAL;
CONSTIPATION;
DEATH;
DEPRESSION;
DRUG EFFECT;
DRUG EFFICACY;
DRUG OVERDOSE;
DRUG SAFETY;
EXTRASYSTOLE;
HEADACHE;
HUMAN;
INSOMNIA;
NAUSEA;
NEUROTOXICITY;
RELAPSE;
REVIEW;
SEIZURE;
SEROTONIN SYNDROME;
SIDE EFFECT;
SINUS TACHYCARDIA;
SOMNOLENCE;
VERTIGO;
WEIGHT GAIN;
XEROSTOMIA;
|
|
EID: 0036019303
PISSN: 0311905X
EISSN: None
Source Type: Journal
DOI: None Document Type: Review |
|
Times cited : (4)
|
|
References (65)
|
